As of December 2024, InnoPharmax has a market cap of $57.33M. This makes InnoPharmax the world's 24414th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $50.94M | -0.58% |
2023 | $51.24M | 48.71% |
2022 | $34.46M | -32.75% |
2021 | $51.24M | 0.29% |
2020 | $51.09M | 40.98% |
2019 | $36.24M | 66.21% |
2018 | $21.80M | -59.58% |
2017 | $53.94M | -39.92% |
2016 | $89.78M | -48.23% |
2015 | $173.43M | 23.82% |
2014 | $140.07M | -0.94% |
2013 | $141.40M | 18.56% |
2012 | $119.26M | - |